Contact
searchSearch
HMP Global
Login

Anxiety Disorders Topic Center

A woman lies on the couch holding an ice pack to her head
News
Migraine Nearly Doubles Depression and Anxiety Risk in Cohort Study
03/10/2026
Brionna Mendoza
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2...
03/10/2026
Psych Congress Network
A person's hands typing on a smartphone
News
Smartphone-Delivered Digital CBT Improves Anxiety Symptoms in Adults
12/29/2025
Sarah Fleming
A smartphone-delivered digital cognitive behavioral therapy (DCBT) program significantly improved symptoms of generalized anxiety disorder (GAD) in adults, according to a randomized clinical trial published in JAMA Network Open.
A smartphone-delivered digital cognitive behavioral therapy (DCBT) program significantly improved symptoms of generalized anxiety disorder (GAD) in adults, according to a randomized clinical trial published in JAMA Network Open.
A smartphone-delivered digital...
12/29/2025
Psych Congress Network
quiz
Quiz
Early Lead Exposure and Mental Health Outcomes
11/10/2025
Maria Mantas
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
11/10/2025
Psych Congress Network
black and white photo of a man
News
Prenatal Lead Exposure Linked to MDD, Anxiety Symptoms in Later Life
10/28/2025
Maria Mantas
Early exposure to lead, particularly in the third trimester of pregnancy, was associated with a higher risk of major depressive disorder and anxiety symptoms in later life, according to cohort study results.
Early exposure to lead, particularly in the third trimester of pregnancy, was associated with a higher risk of major depressive disorder and anxiety symptoms in later life, according to cohort study results.
Early exposure to lead,...
10/28/2025
Psych Congress Network
Conference attendees look at a poster
Conference Coverage
Digital Therapeutic Rejoyn May Aid Anxiety in MDD Patients
09/25/2025
Brionna Mendoza
The digital therapeutic Rejoyn (CT-152) outperformed a sham smartphone app in reduction of anxiety levels in adult patients with major depressive disorder (MDD).
The digital therapeutic Rejoyn (CT-152) outperformed a sham smartphone app in reduction of anxiety levels in adult patients with major depressive disorder (MDD).
The digital therapeutic Rejoyn...
09/25/2025
Psych Congress Network
open and spilled bottle of pills
News
Beta-Blockers Ineffective for Treating Psychological Symptoms of Anxiety
04/24/2025
Maria Mantas
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no...
04/24/2025
Psych Congress Network
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Insights
Clarifying Common Misconceptions About Treating Anxiety in Women
03/30/2025
Moushumi Mukerji, MSN, PMHNP-BC; Vanessa Joy Walker, CPC, MPH
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often...
03/30/2025
Psych Congress NP Institute
From Psych Congress NP Institute
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Insights
Adopting a Life-Stage Lens for Anxiety Treatment in Women
03/29/2025
Moushumi Mukerji, MSN, PMHNP-BC; Vanessa Joy Walker, CPC, MPH
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC,...
03/29/2025
Psych Congress NP Institute
From Psych Congress NP Institute
How many people with anxiety disorders receive treatment?
Quiz
How many people with anxiety disorders receive treatment?
01/28/2025
Test your statistical knowledge!
Test your statistical knowledge!
Test your statistical knowledge!
01/28/2025
Psych Congress Network
How long does worry need to be present in order to diagnose GAD?
Quiz
How long does worry need to be present in order to diagnose GAD?
01/03/2025
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
01/03/2025
Psych Congress Network
A woman sits on the floor looking sad and worried.
News
FDA OKs Digital Therapeutic for Generalized Anxiety Disorder
09/13/2024
Brionna Mendoza
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug...
09/13/2024
Psych Congress Network

News Articles

A woman lies on the couch holding an ice pack to her head
News
Migraine Nearly Doubles Depression and Anxiety Risk in Cohort Study
03/10/2026
Brionna Mendoza
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2...
03/10/2026
Psych Congress Network
A person's hands typing on a smartphone
News
Smartphone-Delivered Digital CBT Improves Anxiety Symptoms in Adults
12/29/2025
Sarah Fleming
A smartphone-delivered digital cognitive behavioral therapy (DCBT) program significantly improved symptoms of generalized anxiety disorder (GAD) in adults, according to a randomized clinical trial published in JAMA Network Open.
A smartphone-delivered digital cognitive behavioral therapy (DCBT) program significantly improved symptoms of generalized anxiety disorder (GAD) in adults, according to a randomized clinical trial published in JAMA Network Open.
A smartphone-delivered digital...
12/29/2025
Psych Congress Network
black and white photo of a man
News
Prenatal Lead Exposure Linked to MDD, Anxiety Symptoms in Later Life
10/28/2025
Maria Mantas
Early exposure to lead, particularly in the third trimester of pregnancy, was associated with a higher risk of major depressive disorder and anxiety symptoms in later life, according to cohort study results.
Early exposure to lead, particularly in the third trimester of pregnancy, was associated with a higher risk of major depressive disorder and anxiety symptoms in later life, according to cohort study results.
Early exposure to lead,...
10/28/2025
Psych Congress Network
open and spilled bottle of pills
News
Beta-Blockers Ineffective for Treating Psychological Symptoms of Anxiety
04/24/2025
Maria Mantas
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no...
04/24/2025
Psych Congress Network
A woman sits on the floor looking sad and worried.
News
FDA OKs Digital Therapeutic for Generalized Anxiety Disorder
09/13/2024
Brionna Mendoza
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug...
09/13/2024
Psych Congress Network
An older woman sits alone
News
New-Onset Anxiety Increases PD Risk in Adults 50 and Older
08/27/2024
Jolynn Tumolo
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson...
08/27/2024
Neurology
postpartum depression
News
Digital Health Interventions Show Promise in Alleviating Postpartum Depression and Anxiety
01/05/2024
Meagan Thistle
Digital health interventions modestly but notably reduce postpartum depression and anxiety symptoms compared to ‘treatment as usual,’ a systematic review found.
Digital health interventions modestly but notably reduce postpartum depression and anxiety symptoms compared to ‘treatment as usual,’ a systematic review found.
Digital health interventions...
01/05/2024
Psych Congress Network
Neuroactive Nasal Spray Promising Treatment for SAD
News
Neuroactive Nasal Spray Promising Treatment for SAD
12/07/2023
Evi Arthur
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a...
12/07/2023
Psych Congress Network
Intranasal Fasedienol Safe, Well-Tolerated in Adults With Social Anxiety Disorder
News
Intranasal Fasedienol Safe, Well-Tolerated in Adults With Social Anxiety Disorder
11/20/2023
Jolynn Tumolo
Repeated, as-needed fasedienol was safe and well tolerated, and improved overall symptom control, in adults with social anxiety disorder (SAD), according to a poster presented at NEI Congress in Colorado Springs, Colorado, earlier this month.
Repeated, as-needed fasedienol was safe and well tolerated, and improved overall symptom control, in adults with social anxiety disorder (SAD), according to a poster presented at NEI Congress in Colorado Springs, Colorado, earlier this month.
Repeated, as-needed fasedienol...
11/20/2023
Psych Congress Network
FDA headquarters
News
FDA Issues Warning Highlighting Risks of Ketamine for Psychiatric Disorder Treatment
10/27/2023
Meagan Thistle
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed...
10/27/2023
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy, with a human hand picking up the happy face
News
Semaglutide May Improve Motivation in MDD, Small Trial Finds
05/04/2026
Brionna Mendoza
A randomized clinical trial published in JAMA Psychiatry found that oral semaglutide may improve effort-based decision-making in adults with major depressive disorder (MDD).
A randomized clinical trial published in JAMA Psychiatry found that oral semaglutide may improve effort-based decision-making in adults with major depressive disorder (MDD).
A randomized clinical trial...
05/04/2026
Psych Congress Network
A patient receives psychedelic-assisted therapy
News
Presidential Executive Order Seeks to Expand Psychedelic Access for Tough-To-Treat Mental Illnesses
04/29/2026
Brionna Mendoza
President Donald J. Trump signed an executive order titled “Accelerating Medical Treatments for Serious Mental Illness,” which aims to expand psychedelic therapy access for significant mental health issues, such as suicidality, major...
President Donald J. Trump signed an executive order titled “Accelerating Medical Treatments for Serious Mental Illness,” which aims to expand psychedelic therapy access for significant mental health issues, such as suicidality, major...
President Donald J. Trump signed...
04/29/2026
Psych Congress Network
a female soldier stands in front of a row of American flags
News
TMS Improves Residential Therapy Outcomes in Combat-Related PTSD
04/22/2026
Maria Mantas
Active navigated transcranial magnetic stimulation (TMS) added to intensive residential treatment was associated with greater reduction of symptoms in patients with combat-related posttraumatic stress disorder (PTSD) than sham TMS.
Active navigated transcranial magnetic stimulation (TMS) added to intensive residential treatment was associated with greater reduction of symptoms in patients with combat-related posttraumatic stress disorder (PTSD) than sham TMS.
Active navigated transcranial...
04/22/2026
Psych Congress Network
A doctor sits at a table holding a pill bottle in one hand while filling out paperwork
News
Algorithm-Guided Treatment Improves Outcomes in Major Depressive Disorder
04/14/2026
Brionna Mendoza
A systematic review published in Frontiers in Psychiatry reports that algorithm-guided treatment (AGT) is generally associated with improved remission rates and more timely treatment modifications compared with treatment as usual (TAU).
A systematic review published in Frontiers in Psychiatry reports that algorithm-guided treatment (AGT) is generally associated with improved remission rates and more timely treatment modifications compared with treatment as usual (TAU).
A systematic review published in...
04/14/2026
Psych Congress Network
a person attempts to pick up a glass of water
News
Valbenazine Demonstrates Higher Persistence vs Deutetrabenazine in TD Patients
04/14/2026
Maria Mantas
Neurocrine Biosciences reported new real-world evidence demonstrating higher treatment persistence with valbenazine (Ingrezza) compared with deutetrabenazine (Austedo XR) among adults with tardive dyskinesia (TD).
Neurocrine Biosciences reported new real-world evidence demonstrating higher treatment persistence with valbenazine (Ingrezza) compared with deutetrabenazine (Austedo XR) among adults with tardive dyskinesia (TD).
Neurocrine Biosciences reported...
04/14/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
News
Open-Label Extension Trial Supports Long-Term Use of Viloxazine ER in Children and Adolescents
04/13/2026
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension...
04/13/2026
Psych Congress Network
A teddy bear against a blue background wearing a mask and stethoscope.
News

ADHD Incidence Trends Accelerated After DSM-5 Changes and COVID-19 Disruptions
04/10/2026
Brionna Mendoza
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity...
04/10/2026
Psych Congress Network
A profile of a person split in half, one half teal and the other purple, with a swirl line over the head
News
Higher Risk of Premature Death Found in Bipolar II Disorder
04/07/2026
Brionna Mendoza
Bipolar II disorder (BD-II) is associated with significantly increased mortality, according to a large population-based cohort study published in JAMA Network Open.
Bipolar II disorder (BD-II) is associated with significantly increased mortality, according to a large population-based cohort study published in JAMA Network Open.
Bipolar II disorder (BD-II) is...
04/07/2026
Psych Congress Network
a man with depression looks out a window major depressive disorder
Research Summary
Psilocybin Produces Mixed Outcomes in Phase 2b MDD Study
04/01/2026
Brionna Mendoza
A Phase 2b randomized clinical trial found nonsignificant differences in response rate between psilocybin 25 mg, psilocybin 5 mg, and placebo with supporting psychotherapy in treatment-resistant major depressive disorder (MDD).
A Phase 2b randomized clinical trial found nonsignificant differences in response rate between psilocybin 25 mg, psilocybin 5 mg, and placebo with supporting psychotherapy in treatment-resistant major depressive disorder (MDD).
A Phase 2b randomized clinical...
04/01/2026
Psych Congress Network
spilled bottle of white pills
News
Tazbentetol Demonstrates Early Symptom Improvement in Phase 2 Schizophrenia Trial
04/01/2026
Maria Mantas
Interim results from a phase 2 randomized, double-blind, placebo-controlled trial of tazbentetol demonstrated early signals of efficacy across schizophrenia symptom domains.
Interim results from a phase 2 randomized, double-blind, placebo-controlled trial of tazbentetol demonstrated early signals of efficacy across schizophrenia symptom domains.
Interim results from a phase 2...
04/01/2026
Psych Congress Network

Practice Tools

Saundra's Corner
Hamilton Anxiety Rating Scale (HAM-A)
01/28/2019
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
...
01/28/2019
Psych Congress Network
Saundra's Corner
Social Phobia Inventory (SPIN)
09/28/2016
How to Use Valid measure of severity of social phobia symptoms Patient-rated assessment of the three clinically important symptom domains of social phobia Sensitive to the reduction in symptoms over time Brief, simple and easy to...
How to Use Valid measure of severity of social phobia symptoms Patient-rated assessment of the three clinically important symptom domains of social phobia Sensitive to the reduction in symptoms over time Brief, simple and easy to...
How to Use Valid measure of...
09/28/2016
Psych Congress Network
Saundra's Corner
Mini-Social Phobia Inventory (Mini-SPIN)
09/28/2016
How to Use Screening tool for social anxiety disorder (SAD) developed by Dr. Jonathan Davidson of Duke University Medical Center  Based on the longer 17-item social phobia inventory (SPIN)  Self-rated scale 3-items about...
How to Use Screening tool for social anxiety disorder (SAD) developed by Dr. Jonathan Davidson of Duke University Medical Center  Based on the longer 17-item social phobia inventory (SPIN)  Self-rated scale 3-items about...
How to Use Screening tool...
09/28/2016
Psych Congress Network
Saundra's Corner
Generalized Anxiety Disorder-7 (GAD-7)
09/28/2016
How to Use the GAD-7 Patients circle one of the 4 numbers (representing severity) associated with 7 problems. If patients identify any problems, they then indicate (by checking the appropriate box) the degree to which these problems made it...
How to Use the GAD-7 Patients circle one of the 4 numbers (representing severity) associated with 7 problems. If patients identify any problems, they then indicate (by checking the appropriate box) the degree to which these problems made it...
How to Use the GAD-7 Patients...
09/28/2016
Psych Congress Network
Saundra's Corner
Anxiety Disorders
09/28/2016
Generalized Anxiety Disorder-7 (GAD-7) Hamilton Anxiety Rating Scale (HAM-A) Mini-Social Phobia Inventory (Mini SPIN) Social Phobia Inventory (SPIN)
Generalized Anxiety Disorder-7 (GAD-7) Hamilton Anxiety Rating Scale (HAM-A) Mini-Social Phobia Inventory (Mini SPIN) Social Phobia Inventory (SPIN)
Generalized Anxiety...
09/28/2016
Psych Congress Network
Saundra's Corner
Medication Adherence Rating Scale (MARS)
01/29/2019
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for...
01/29/2019
Psych Congress Network
Saundra's Corner
Sheehan Disability Scale (SDS)
01/28/2019
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS...
01/28/2019
Psych Congress Network
Saundra's Corner
Brief Psychiatric Rating Scale (BPRS)
01/28/2019
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
...
01/28/2019
Psych Congress Network
Saundra's Corner
The Mini International Neuropsychiatric Interview
01/28/2019
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is...
01/28/2019
Psych Congress Network
Saundra's Corner
MINI Screen
01/28/2019
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen...
01/28/2019
Psych Congress Network
Saundra's Corner
Patient Health Questionnaire (PHQ-9)
01/28/2019
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health...
01/28/2019
Psych Congress Network
Saundra's Corner
WHO (Five) Well-Being Index (WHO-5)
01/28/2019
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated...
01/28/2019
Psych Congress Network
Saundra's Corner
Beck Depression Inventory-II (BDI-II)
01/28/2019
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to...
01/28/2019
Psych Congress Network
Saundra's Corner
Mood Disorder Questionnaire (MDQ)
01/28/2019
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder...
01/28/2019
Psych Congress Network
Saundra's Corner
Hamilton Anxiety Rating Scale (HAM-A)
01/28/2019
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
...
01/28/2019
Psych Congress Network

Interactive Features

quiz
Quiz
Early Lead Exposure and Mental Health Outcomes
11/10/2025
Maria Mantas
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
11/10/2025
Psych Congress Network
How many people with anxiety disorders receive treatment?
Quiz
How many people with anxiety disorders receive treatment?
01/28/2025
Test your statistical knowledge!
Test your statistical knowledge!
Test your statistical knowledge!
01/28/2025
Psych Congress Network
How long does worry need to be present in order to diagnose GAD?
Quiz
How long does worry need to be present in order to diagnose GAD?
01/03/2025
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
01/03/2025
Psych Congress Network
How many weeks must separation anxiety symptoms be present to diagnose children?
Quiz
How many weeks must separation anxiety symptoms be present to diagnose children?
11/10/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
11/10/2023
Psych Congress Network
quiz
Quiz
Which symptoms indicate a panic disorder diagnosis?
03/30/2023
Do you know which diagnostic criteria symptoms must be present to make a panic disorder diagnosis? Take the quiz to find out!
Do you know which diagnostic criteria symptoms must be present to make a panic disorder diagnosis? Take the quiz to find out!
Do you know which diagnostic...
03/30/2023
Psych Congress Network
By how much did deep brain stimulation reduce OCD symptoms?
Quiz
By how much did deep brain stimulation reduce OCD symptoms?
12/12/2022
Test your knowledge with a quick quiz!
Test your knowledge with a quick quiz!
Test your knowledge with a quick...
12/12/2022
Psych Congress Network
Quiz
Quiz
What percent of adults report anxiety relating to their mental health?
01/28/2022
According to a recent APA poll, what percent of adults say that they have anxiety relating to their mental health?
According to a recent APA poll, what percent of adults say that they have anxiety relating to their mental health?
According to a recent APA poll,...
01/28/2022
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Mortality Risk in Bipolar II Disorder
04/30/2026
Maria Mantas
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between...
04/30/2026
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
PGx Testing in MDD
04/27/2026
Maria Mantas
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of...
04/27/2026
Psych Congress Network
a girl playing a game on a tablet while lying on her stomach
Quiz
Test Your Knowledge—Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx...
04/23/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
Quiz
Long-Term Effects of Viloxazine ER in Treatment of Pediatric ADHD
04/23/2026
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test...
04/23/2026
Psych Congress Network
Brooke Kempf, PMHNP-BC, and Jonathan Meyer, MD
Quiz
Why should anticholinergics be avoided in TD?
04/17/2026
Maria Mantas
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why...
04/17/2026
Psych Congress Network
Brooke Kempf, PMHNP-BC, and Jonathan Meyer, MD
Quiz
Why should anticholinergics be avoided in TD?
04/17/2026
Maria Mantas
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why anticholinergic agents aren't appropriate treatment options for tardive dyskinesia? Test your knowledge with this quiz!
Do you remember why...
04/17/2026
Psych Congress Network
Edward Kaftarian, MD
Quiz
Legal Considerations in Cross-State Telepsychiatry
03/23/2026
Maria Mantas
Test your knowledge with this faculty insights quiz!
Test your knowledge with this faculty insights quiz!
Test your knowledge with this...
03/23/2026
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Pharmacologic Intervention in Bulimia Nervosa
02/26/2026
Maria Mantas
Do you remember what the APA guideline recommends? Test your knowledge with this quiz!
Do you remember what the APA guideline recommends? Test your knowledge with this quiz!
Do you remember what the APA...
02/26/2026
Psych Congress Network
blocks spelling out the word "quiz"
Quiz
Screen Time, Brain Structure, and ADHD in Children
02/12/2026
Maria Mantas
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the...
02/12/2026
Psych Congress Network
An illustration of a pencil marking answers on a quiz sheet.
Quiz
Intranasal Esketamine Dosage for Adult MDD
02/04/2026
Brionna Mendoza
Test your prescribing and administration knowledge with this quiz!
Test your prescribing and administration knowledge with this quiz!
Test your prescribing and...
02/04/2026
Psych Congress Network

Blogs
Blog
Reducing the Burden of Generalized Anxiety Disorder
04/14/2021
Urgent action is needed from mental health providers to reduce the public health burden of anxiety disorders, which are widely prevalent yet often go undiagnosed, Anxiety Disorders Section Editor Manish K. Jha, MBBS, says.
Urgent action is needed from mental health providers to reduce the public health burden of anxiety disorders, which are widely prevalent yet often go undiagnosed, Anxiety Disorders Section Editor Manish K. Jha, MBBS, says.
Urgent action is needed from...
04/14/2021
Psych Congress Network
Blog
Are Benzodiazepines the Next Opioid Crisis?
02/19/2019
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: A study recently published in JAMA found that as our profession has been working tirelessly to curtail prescriptions for opioids we are prescribing more and more benzodiazepines.
BLOG: A study recently published in JAMA found that as our profession has been working tirelessly to curtail prescriptions for opioids we are prescribing more and more benzodiazepines.
BLOG: A study recently published...
02/19/2019
Psych Congress Network
Blog
Psilocybin Studies: A New Ray of Hope for Psychiatry?
12/01/2016
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: These studies were the latest findings showing that psychedelics, erroneously dismissed as mere intoxicants and swept up in the hysteria of the Nixon-era drug wars, could prove to be as important to psychiatry as penicillin was to...
BLOG: These studies were the latest findings showing that psychedelics, erroneously dismissed as mere intoxicants and swept up in the hysteria of the Nixon-era drug wars, could prove to be as important to psychiatry as penicillin was to...
BLOG: These studies were the...
12/01/2016
Psych Congress Network
Blog
Psychedelics: What to Tell Patients Today
08/25/2015
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Psychedelic compounds are powerful, and they have great potential to help patients with intractable conditions. Yet any compound with that kind of power also has the potential to harm, and that harm should not be trivialized.
Psychedelic compounds are powerful, and they have great potential to help patients with intractable conditions. Yet any compound with that kind of power also has the potential to harm, and that harm should not be trivialized.
Psychedelic compounds are...
08/25/2015
Psych Congress Network
marc agronin md
Faculty Insights
Alzheimer Disease Prevention: Part 2
07/29/2024
Marc E. Agronin, MD
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated...
07/29/2024
Psych Congress Network
Rakesh Amin, MD.
Blog
Treating Schizophrenia: The Importance of Early Identification and Intervention
06/13/2023
Rakesh Amin, MD
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the...
06/13/2023
Psych Congress Network
Marc Agronin, MD.
Blog
Alzheimer Disease Prevention
08/30/2022
Marc E. Agronin, MD
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section...
08/30/2022
Psych Congress Network
Ed Jones, PhD
Blog
How Our Clinicians Can Help Fix the US Health Care System
07/28/2022
Ed Jones, PhD
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the...
07/28/2022
Psych Congress Network
Ed Jones, PhD
Perspective
The Universal Behavior Model: A Comprehensive Approach to Integrated Care
07/21/2022
Ed Jones, PhD
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this...
07/21/2022
Psych Congress Network
Chan_Khan_Digital Mental Health
Blog
Who will use it? How to Get Digital Mental Health Apps Into the Hands of Patients
04/27/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan...
04/27/2022
Psychiatry & Behavioral Health
Chan_Khan_Digital Mental Health
Blog
How to Navigate Quality Issues With Mental Health Apps
04/21/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan...
04/21/2022
Psychiatry & Behavioral Health
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Blog
How New NPs Can Find Mentors
03/04/2022
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains...
03/04/2022
Psych Congress Network
Julie Bailey
Blog
How to Be a Safe Space for Someone
02/08/2022
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey,...
02/08/2022
Psych Congress Network
major depressive disorder
Blog
The Best and Worst Changes Brought On By the Pandemic
01/31/2022
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy...
01/31/2022
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use